Photo credit: Courtesy of Dr. Tomlinson

As artificial intelligence reshapes medicine, Dr. Mu Tomlinson is helping lead a new era of healthcare defined by innovation, human judgment and the pursuit of untapped potential.

In an industry undergoing one of the most significant technological transformations in its history, Dr. Mu Tomlinson occupies a distinctive position. An award-winning physician, healthcare executive and CEO of Vituity, Tomlinson brings together frontline medical experience, executive leadership and a deep interest in the forces that will shape the future of healthcare.

His career has taken him from emergency medicine to the highest levels of healthcare leadership, giving him a perspective that bridges two worlds: the immediate realities of caring for patients and the long-term challenge of transforming the systems in which that care takes place.

As artificial intelligence becomes increasingly embedded in healthcare, that perspective has become particularly relevant.

The promise of AI extends across virtually every stage of the healthcare journey. From diagnostics and medical imaging to clinical workflows, documentation and precision medicine, intelligent technologies are creating opportunities to process information faster, identify patterns earlier and potentially improve the way healthcare professionals make decisions.

For Tomlinson, however, the significance of AI is not simply about technological advancement. Its greatest opportunity may lie in exposing and reducing the friction that has become embedded within healthcare systems.

Healthcare professionals operate in an environment where time is often consumed by administrative requirements, documentation and coordination. These demands can compete directly with the time available for patient care. AI has the potential to automate portions of these processes, allowing physicians and other clinicians to concentrate more heavily on the areas where human expertise remains indispensable.

The distinction is important. AI can process enormous quantities of information and recognise patterns at extraordinary speed, but medicine is not simply an exercise in pattern recognition. Clinical decisions involve context, responsibility, communication, empathy and an understanding of the individual patient.

The emerging model of healthcare is therefore less about replacing physicians and more about augmenting their capabilities.

That philosophy is consistent with Tomlinson’s own evolution as a healthcare leader.

Before becoming a prominent healthcare executive, he built his career in emergency medicine, where decisions often have to be made quickly and under considerable pressure. During his tenure with Adventist Health Central Valley Network, he served as Chief of Staff and established the network’s Department of Emergency and Diagnostic Medicine. He also served as Medical Director of Adventist Health’s Hanford and Selma Emergency Departments.

Those experiences provided an unusually close view of the challenges confronting physicians, patients and healthcare organisations.

Emergency medicine demands prioritisation, teamwork and the ability to make consequential decisions despite incomplete information. Those qualities have subsequently informed Tomlinson’s approach to leadership and innovation.

His influence now extends well beyond the hospital environment.

In 2025, Tomlinson appeared alongside Venus Williams at Becker’s Healthcare Conference, delivered a keynote at the Black Student-Athlete Summit and participated in a leadership panel at SXSW. His work has also attracted recognition from major media organisations, including Modern Healthcare, Forbes, the Los Angeles Times and CBS.

Yet his leadership philosophy extends beyond technology.

At the centre of Tomlinson’s broader body of work is a recurring interest in potential—particularly the potential of people who are overlooked, underestimated or excluded by conventional systems.

That idea is explored in his book Less Than One Percent, which features a foreword by Magic Johnson. Drawing lessons from overlooked athletes and extraordinary underdogs, the book examines talent, leadership, systemic bias and the untapped potential that exists within medicine and society.

The concept is particularly relevant to organisations navigating technological disruption.

Innovation rarely comes exclusively from established patterns of thinking. Transformational ideas can emerge from people whose backgrounds, experiences or approaches fall outside traditional expectations. For businesses and healthcare institutions, recognising those individuals can be as important as investing in new technology.

Tomlinson has continued this conversation through the Less Than One Percent podcast, bringing together perspectives from sports, technology and business.

His commitment to developing future leaders also extends into community work through the 24/7 Foundation, where empowering young people forms an important part of his wider mission.

This emphasis on opportunity creates a clear connection between his leadership philosophy and his approach to healthcare innovation.

The future of medicine will require more than sophisticated algorithms. It will require people capable of asking better questions about how those algorithms are used, who benefits from them and how their impact should be measured.

That question becomes particularly important when considering equity.

Artificial intelligence could potentially expand access to expertise, improve early intervention and enable more personalised approaches to treatment. Precision medicine, supported by increasingly sophisticated data analysis, could allow healthcare professionals to better understand individual patient characteristics and tailor care accordingly.

But technology does not automatically eliminate inequality.

If AI systems are developed using incomplete or biased information, those shortcomings can potentially be reproduced at scale. If access to advanced technologies remains concentrated within better-resourced healthcare environments, technological progress could also widen existing disparities.

Responsible innovation therefore requires both ambition and discipline.

For healthcare leaders, the challenge is not simply deciding whether to adopt AI. It is determining where it can solve meaningful problems, how it should be integrated into clinical environments, how outcomes should be measured and how patient trust can be protected.

This is where Tomlinson’s combination of clinical experience and executive leadership becomes particularly significant.

He represents a generation of healthcare leaders increasingly required to operate at the intersection of medicine, technology, business and social responsibility.

The transformation of healthcare will not happen through technology alone. It will occur through the interaction of technology with clinicians, patients, administrators, researchers and leaders who understand both its possibilities and its limitations.

For Tomlinson, the ultimate measure of innovation is therefore not how advanced a system appears, but what it enables people to do better.

A physician who can spend more time with a patient because documentation has been streamlined represents progress. A diagnostic process that identifies risk earlier represents progress. A healthcare system that can deliver more personalised care while reducing unnecessary friction represents progress.

These individual improvements may appear incremental, but collectively they have the potential to reshape the patient and physician experience.

Tomlinson’s career reflects that broader transformation. From the emergency department to the executive suite, from clinical medicine to conversations on some of the world’s most prominent stages, his work has increasingly focused on what happens when traditional assumptions are challenged.

His story is ultimately not just about artificial intelligence.

It is about the future of leadership.

It is about recognising potential before it becomes obvious. It is about creating systems that empower people rather than burden them. And it is about understanding that innovation has little value if it does not ultimately improve the human experience.

As healthcare enters an era defined by unprecedented technological capability, leaders will face an equally unprecedented responsibility to determine how that capability is used.

The most consequential advances may not come from technology replacing the human element of medicine, but from technology giving that human element more room to flourish.

For Dr. Mu Tomlinson, that intersection represents both the challenge and the opportunity ahead: building a healthcare future in which innovation, leadership and human potential are not competing forces, but interconnected drivers of progress.